BridgeBio Oncology Therapeutics, Inc. (BBOT) — Long-term Investment Intensity
BridgeBio Oncology Therapeutics, Inc. (BBOT) has a Long-term Investment Intensity of 32.7% as of March 2026. Long-term investments of $136.62 Million represent 32.7% of total assets of $417.65 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check BridgeBio Oncology Therapeutics, Inc. (BBOT) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Annual Long-term Investment Intensity for BridgeBio Oncology Therapeutics, Inc. (None–None)
The table below presents the year-by-year Long-term Investment Intensity for BridgeBio Oncology Therapeutics, Inc. from None to None, covering 0 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see BridgeBio Oncology Therapeutics, Inc. stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|